Protalix is a publicly traded biotechnology company (AMEX: PLX), that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.

Investor Relations

Thank you for interest in Protalix Biotherapeutics. For questions and comments, please feel free to contact us at the addresses listed below.

Investor Relations

Marcy Strickler
The Trout Group LLC
740 Broadway, 9th Floor
New York, NY 10003
T:   646-378-2927
F:  646-378-2901
E:   

Tim Ryan
The Trout Group LLC
740 Broadway, 9th Floor
New York, NY 10003
T:  646-378-2924
F:  646-378-2901
E:   

General

Yossi Maimon, CFO

Protalix Biotherapeutics
2 Snunit St., Science Park,
POB 455, Karmiel 20100, Israel.

T:  +972-4-902-8100, Extension 143
F:  +972-4-988-9489
E:   

© 2008 Protalix Biotherapeutics. All Rights Reserved.